Myosin Light Chain 2, Regulatory, Cardiac (MYL2)

CMH10; MLC2; Myosin,Light Chain 2,Regulatory,Cardiac,Slow; Myosin regulatory light chain 2, ventricular/cardiac muscle isoform

SPN	V711
HGNC	7583
MGI	97272
PubMed	1386340
RGD	3141
UniProt	P10916
Wiki	MYL2

Myosin regulatory light chain 2, ventricular/cardiac muscle isoform is the regulatory light chain associated with cardiac myosin beta (or slow) heavy chain. Ca+ triggers the phosphorylation of regulatory light chain that in turn triggers contraction. Mutations in MYL2 are associated with mid-left ventricular chamber type hypertrophic cardiomyopathy.The 2 pairs of light chains of muscle myosins are called essential light chains (ELC) and regulatory light chains (RLC).

The light chains stabilize the long alpha helical neck of the myosin head. Myosin light chain-2 (MYL2) is an important protein in the regulation of myosin ATPase activity in smooth muscle. An increase in ventricular MYL2 is observed in the hypertrophied myocardium of cardiac patients with valvular stenosis.

Reference

"Isolation and nucleotide sequence of the cDNA encoding human ventricular myosin light chain 2."
Nucleic Acids Res. 17:2360-2360(1989) [PubMed] [Europe PMC] [Abstract]

"Interaction of a conserved peptide domain in recombinant human ventricular myosin light chain-2 with myosin heavy chain."
Cell. Mol. Biol. Res. 39:13-26(1993) [PubMed] [Europe PMC] [Abstract]

"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]

"The major protein expression profile and two-dimensional protein database of human heart."
Electrophoresis 16:1160-1169(1995) [PubMed] [Europe PMC] [Abstract]

"Protein interactions with myocilin."
Invest. Ophthalmol. Vis. Sci. 43:176-182(2002) [PubMed] [Europe PMC] [Abstract]

"Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle."
Nat. Genet. 13:63-69(1996) [PubMed] [Europe PMC] [Abstract]

"Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy."
J. Mol. Med. 76:208-214(1998) [PubMed] [Europe PMC] [Abstract]

"Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy."
Eur. J. Hum. Genet. 10:741-748(2002) [PubMed] [Europe PMC] [Abstract]

"Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy."
Circulation 107:2227-2232(2003) [PubMed] [Europe PMC] [Abstract]

Erratum
Circulation 109:3258-3258(2004)

"Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden."
J. Mol. Cell. Cardiol. 35:841-849(2003) [PubMed] [Europe PMC] [Abstract]